• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

deal

  1. United Therapeutics signs a deal with Arena

    United Therapeutics signs an agreement with Arena in a deal worth $1.2 billion. It will pay $800 million as upfront payment to Arena and $400 million as potential milestone payments. This is what exactly Arena investors have been looking for. This will be a win-win deal for both the companies...
    • anonymous
    • Thread
    • agreement arena pharmaceuticals clinical trial deal drug fda pulmonary arterial hypertension united therapeutics
    • Replies: 0
    • Forum: United Therapeutics

  2. Stryker says it will not acquire Boston Scientific

    On Monday, WSJ reported that Stryker is in talks with Boston Scientific for a potential acquisition. But today, Stryker confirmed that it didn't have any discussion with Boston Scientific. https://news.alphastreet.com/stryker-confirms-that-it-didnt-bid-for-boston-scientific/
    • anonymous
    • Thread
    • acquisition boston scientific bostonscientific deal healthcare medical device medical equipment merger rumor stryker
    • Replies: 5
    • Forum: Boston Scientific

  3. Things happened in healthcare in 2017

    If you ask Sansa Stark from HBO’s Game of Thrones, she’ll tell you the best way to go is to team up with someone strong or risk getting killed. And that’s what happens to most acquisitions in the market nowadays. Over the past three years or so, we have seen a plethora of deal announcements...

  4. A bad move by Allergan

    I don't know why Allergan is buying this struggling penny stock company. I don't think Allergan can do what Repros couldn’t and deliver the safety data that the FDA is looking for.
    • anonymous
    • Thread
    • acquisition allergan buyout deal repros
    • Replies: 10
    • Forum: Allergan

  5. Oncology collaboration

    Lilly signs a deal with Germany-based Curevac to strengthen its oncology division. http://alph.st/b72eaf5f
    • anonymous
    • Thread
    • agreement cancer treatment deal eli lilly immuno-oncology oncology
    • Replies: 1
    • Forum: Eli Lilly

  6. Mylan wins the battle

    Texas court says Allergan's Mohawk Tribe patent deal is invalid. Earlier, Mylan had fired back at rival Allergan's attempt to shield its patent for Restasis.
    • anonymous
    • Thread
    • deal mylan patent
    • Replies: 1
    • Forum: Mylan

  7. Allergan gets a major blow

    Texas court says Mohawk Tribe patent deal is not legit. "The Court has serious concerns about the legitimacy of the tactic that Allergan and the Tribe have employed," Judge William Bryson said in a memorandum opinion accompanying his decision.
    • anonymous
    • Thread
    • allergan deal patent
    • Replies: 2
    • Forum: Allergan

  8. How Brent Saunders will defend Allergan's unfair move?

    Will Congress take any action on the letter from 10 lobbying groups?
    • anonymous
    • Thread
    • allergan deal
    • Replies: 5
    • Forum: Allergan

  9. Will this partnership help Lilly in the long run?

    Eli Lilly join hands with Nektar to co-develop NKTR-358, Because of the $400 million deal, Lilly has reduced its outlook.
    • Norman Foster
    • Thread
    • deal eli lilly nektar therapeautics partnership
    • Replies: 0
    • Forum: Eli Lilly
Top Bottom
Back